Study of ASN51 in Adults With Early Alzheimer's Disease

Clinical trial NCT06677203 · TERMINATED

Trial details

NCT number: NCT06677203
Sponsor: Asceneuron S.A.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-10-16
Primary completion: 2024-11-08
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.